Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 34% ± 15% | |
oligodendrocyte | 4 studies | 26% ± 12% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 9% | |
microglial cell | 3 studies | 18% ± 4% | |
myeloid cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 48% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1182.95 | 2640 / 2642 | 100% | 3.23 | 702 / 705 |
esophagus | 100% | 1420.77 | 1445 / 1445 | 98% | 2.50 | 180 / 183 |
thymus | 100% | 1660.00 | 653 / 653 | 98% | 2.57 | 592 / 605 |
lung | 100% | 1754.09 | 578 / 578 | 96% | 2.37 | 1114 / 1155 |
prostate | 100% | 1270.50 | 245 / 245 | 96% | 2.09 | 484 / 502 |
breast | 100% | 1428.70 | 459 / 459 | 95% | 2.55 | 1064 / 1118 |
intestine | 100% | 1323.97 | 966 / 966 | 93% | 1.99 | 490 / 527 |
uterus | 100% | 1019.22 | 170 / 170 | 93% | 2.24 | 426 / 459 |
stomach | 100% | 1158.30 | 359 / 359 | 92% | 1.82 | 262 / 286 |
kidney | 100% | 1601.40 | 89 / 89 | 92% | 2.17 | 825 / 901 |
bladder | 100% | 1133.71 | 21 / 21 | 91% | 2.07 | 460 / 504 |
pancreas | 99% | 762.00 | 325 / 328 | 89% | 1.70 | 159 / 178 |
skin | 100% | 2070.55 | 1809 / 1809 | 85% | 2.04 | 403 / 472 |
adrenal gland | 100% | 2366.52 | 258 / 258 | 80% | 1.53 | 184 / 230 |
ovary | 100% | 932.89 | 180 / 180 | 67% | 1.10 | 288 / 430 |
liver | 100% | 1140.76 | 226 / 226 | 56% | 0.90 | 228 / 406 |
adipose | 100% | 1355.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1110.10 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1507.73 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1200.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 2.08 | 44 / 45 |
peripheral blood | 98% | 1541.15 | 907 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 2.29 | 28 / 29 |
heart | 94% | 1040.48 | 811 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 1.30 | 45 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097745 | Biological process | mitochondrial tRNA 5'-end processing |
GO_0001682 | Biological process | tRNA 5'-leader removal |
GO_0030678 | Cellular component | mitochondrial ribonuclease P complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0005739 | Cellular component | mitochondrion |
GO_0004526 | Molecular function | ribonuclease P activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PRORP |
Protein name | Protein only RNase P catalytic subunit Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit) |
Synonyms | KIAA0391 MRPP3 |
Description | FUNCTION: Catalytic ribonuclease component of mitochondrial ribonuclease P, a complex composed of TRMT10C/MRPP1, HSD17B10/MRPP2 and PRORP/MRPP3, which cleaves tRNA molecules in their 5'-ends . The presence of TRMT10C/MRPP1, HSD17B10/MRPP2 is required to catalyze tRNA molecules in their 5'-ends . . |
Accessions | O15091 ENST00000604948.5 [O15091-4] S4R3S1 ENST00000605201.1 ENST00000250377.11 [O15091-2] ENST00000603611.5 ENST00000604073.1 ENST00000603544.5 [O15091-2] ENST00000557404.3 S4R3T4 A0A0A0MTQ0 S4R416 ENST00000534898.9 [O15091-1] ENST00000321130.14 [O15091-3] ENST00000605870.5 [O15091-3] |